Compare OTIS & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OTIS | BNTX |
|---|---|---|
| Founded | 1853 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Appliances | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.5B | 24.7B |
| IPO Year | 2019 | 2019 |
| Metric | OTIS | BNTX |
|---|---|---|
| Price | $70.18 | $100.83 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 13 |
| Target Price | $99.63 | ★ $133.46 |
| AVG Volume (30 Days) | ★ 3.2M | 1.6M |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.30% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.99 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.94 | N/A |
| Revenue Next Year | $4.83 | $3.37 |
| P/E Ratio | $34.72 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $67.64 | $79.81 |
| 52 Week High | $94.20 | $124.00 |
| Indicator | OTIS | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 45.53 | 49.89 |
| Support Level | $69.72 | $88.36 |
| Resistance Level | $75.17 | $112.78 |
| Average True Range (ATR) | 1.12 | 2.81 |
| MACD | -0.19 | -1.37 |
| Stochastic Oscillator | 50.30 | 21.24 |
Otis is the largest global elevator and escalator supplier by revenue with around 18% global market share. In 1854 Otis' founder and namesake Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed. The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15- to 20-year useful life of an elevator. As the largest global OEM, Otis has amassed an installed base under service that exceeds 2 million elevators. Its business model is similar to that of its closest competitors Kone, Schindler, and TK Elevator.
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.